United States · 
Who invested in Cabaletta Bio?
Cabaletta Bio's investors include Cormorant Asset Management, Eli Lilly, Redmile Group, Adage Capital Management and Bain Capital Life Sciences.
20192020202120222023202420252026
$50MRound$150MRound
United States · Funded startup
Who invested in Cabaletta Bio
Funding summaryUpdated 26 Oct 2026
$200Mraised across 2 rounds since 2019, from 2 sources
$50MRound$150MRound
- Latest round
- Round, $150MMay 2026
- Step-upi
- 3×
- Investors
- 5
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Round, $50M Jan 2019
- Biggest round
- $150M Round · May 2026
- Between rounds
- 7.3 years from the last two
The rounds
- May 2026Round$150M5 new
Source recorded
- Jan 2019Round$50M
No investor was named in the report.
Reported by BizjournalsSEC filing: $50M sold, first sale Jan 2019
Founders and team
From Cabaletta Bio's own website and the SEC filings it signed: 7 on the team.
- Anup MardaChief Financial Officer
- Heather Harte-HallChief Compliance Officer
- Nicolette ShermanChief Human Resources Officer
- Steve GavelChief Commercial Officer
- Michael GerardGeneral Counsel
- Dan GeffkenExecutive Officeri
- Steven NichtbergerExecutive Officer, Directori
On the board, as filediBrian DanielsMark Simon
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Adage Capital ManagementAsset manager1round
Bain Capital Life SciencesPrivate equity1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Cabaletta Bio
How much has Cabaletta Bio raised?
Cabaletta Bio has raised $200M across 2 rounds since 2019.
When did Cabaletta Bio last raise?
Cabaletta Bio's most recent round was an Undisclosed round of $150M in May 2026.
What was Cabaletta Bio's biggest round?
Its most recent round, $150M in May 2026, is also its largest on record.
Who backed Cabaletta Bio first?
Cabaletta Bio's first round on record, in May 2026, was backed by Cormorant Asset Management, Eli Lilly and Redmile Group and 2 others.
What stage is Cabaletta Bio at?
Cabaletta Bio's latest named round is an Undisclosed round, in May 2026.
Where is Cabaletta Bio based?
Cabaletta Bio is based in the United States.
Companies like Cabaletta Bio
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.